Cancel anytime
Afya Ltd (AFYA)AFYA
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
11/20/2024: AFYA (1-star) is a SELL. SELL since 1 days. Profits (-9.56%). Updated daily EoD!
Analysis of Past Performance
Type: Stock | Upturn Star Rating | Today’s Advisory: SELL |
Historic Profit: -57.26% | Upturn Advisory Performance 2 | Avg. Invested days: 22 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 11/20/2024 |
Type: Stock | Today’s Advisory: SELL |
Historic Profit: -57.26% | Avg. Invested days: 22 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 11/20/2024 | Upturn Advisory Performance 2 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.47B USD |
Price to earnings Ratio 14.66 | 1Y Target Price 120.37 |
Dividends yield (FY) - | Basic EPS (TTM) 1.11 |
Volume (30-day avg) 132870 | Beta 0.92 |
52 Weeks Range 15.52 - 22.48 | Updated Date 11/20/2024 |
Company Size Small-Cap Stock | Market Capitalization 1.47B USD | Price to earnings Ratio 14.66 | 1Y Target Price 120.37 |
Dividends yield (FY) - | Basic EPS (TTM) 1.11 | Volume (30-day avg) 132870 | Beta 0.92 |
52 Weeks Range 15.52 - 22.48 | Updated Date 11/20/2024 |
Earnings Date
Report Date 2024-11-14 | When - |
Estimate 1.8362 | Actual 1.79 |
Report Date 2024-11-14 | When - | Estimate 1.8362 | Actual 1.79 |
Profitability
Profit Margin 18.03% | Operating Margin (TTM) 28.5% |
Management Effectiveness
Return on Assets (TTM) 7.11% | Return on Equity (TTM) 15.28% |
Valuation
Trailing PE 14.66 | Forward PE 9.28 |
Enterprise Value 1879825625 | Price to Sales(TTM) 0.48 |
Enterprise Value to Revenue 3.42 | Enterprise Value to EBITDA 8.54 |
Shares Outstanding 46645200 | Shares Floating 1500810 |
Percent Insiders 84.14 | Percent Institutions 23.06 |
Trailing PE 14.66 | Forward PE 9.28 | Enterprise Value 1879825625 | Price to Sales(TTM) 0.48 |
Enterprise Value to Revenue 3.42 | Enterprise Value to EBITDA 8.54 | Shares Outstanding 46645200 | Shares Floating 1500810 |
Percent Insiders 84.14 | Percent Institutions 23.06 |
Analyst Ratings
Rating 3.5 | Target Price 21.47 | Buy 2 |
Strong Buy 1 | Hold 5 | Sell - |
Strong Sell - |
Rating 3.5 | Target Price 21.47 | Buy 2 | Strong Buy 1 |
Hold 5 | Sell - | Strong Sell - |
AI Summarization
Afya Ltd: A Comprehensive Overview
Company Profile
History and Background
Afya Limited is a Brazilian company founded in 2012, dedicated to providing education with a focus on healthcare professionals. The company initially offered in-person courses, then expanded to online education in 2014. In 2018, they acquired Medcel, a leading digital platform for medical professionals in Brazil, consolidating their position in the digital health education market. Afya currently has a presence in Brazil, Mexico, and Colombia.
Core Business Areas
- Medical Education: Afya offers undergraduate and postgraduate medical courses, nursing programs, and specialized courses in various healthcare fields. They operate through their brands, São Camilo, UniA, and FAM, with a strong presence across Brazil.
- Digital Health Education: Afya provides a comprehensive platform for online medical education through Medcel. The platform offers a diverse range of courses, including postgraduate programs, medical specialties, and continuing education.
Leadership and Corporate Structure
- CEO: Virgilio Gibbon
- CFO: André Martins
- Board of Directors: Led by Daniel Castanho as Chairman
Afya has a multi-layered organizational structure with independent business units responsible for their respective brands and operations. The company focuses on a decentralized model, granting its business units significant autonomy.
Top Products and Market Share
Top Products
- Medical Degrees: Afya offers undergraduate medical degrees through their institutions, São Camilo, UniA, and FAM, across various campuses in Brazil.
- Medcel Platform: Medcel is their flagship digital platform offering a wide range of online courses for medical professionals, including postgraduate programs, specialized courses, and continuing education.
Market Share
- Afya holds a significant market share in medical education in Brazil, particularly in the private sector.
- Medcel is the leading digital platform for medical education in Brazil, with over 2 million registered users and over 80 thousand paying subscribers.
- Afya's global market share is currently limited, with the majority of its operations concentrated in Brazil.
Competitive Landscape
Afya faces competition from other private universities offering medical degrees in Brazil. In the digital education space, they compete with platforms like Coursera and Udemy. However, Afya differentiates itself through its specialized focus on healthcare and strong brand recognition in the Brazilian market.
Total Addressable Market
The global market for medical education is estimated to be around $23.1 billion in 2023 and is projected to reach $34.9 billion by 2028, growing at a CAGR of 8.9%. The Brazilian medical education market is a significant contributor to this global market, with a growing demand for qualified healthcare professionals.
Financial Performance
Afya's financial performance has been characterized by strong revenue growth in recent years. For the fiscal year ending June 2023, they reported revenue of R$ 2.7 billion, a 48.6% increase year-on-year. The company also reported a net income of R$ 476 million, with a profit margin of 17.6%.
Their balance sheet is strong with healthy cash flow generation. However, they do have a relatively high level of debt, which is primarily associated with acquisitions made in recent years.
Dividends and Shareholder Returns
Afya does not currently pay dividends to shareholders. Their primary focus is on reinvesting profits back into the company to fuel future growth. Total shareholder returns for the past year have been positive, driven by the strong increase in the company's stock price.
Growth Trajectory
Afya has exhibited strong historical growth, fueled by acquisitions and organic expansion. Future growth projections suggest continued expansion in both their traditional and online education segments. They plan to increase their footprint in the Brazilian market and explore opportunities for international expansion, potentially targeting other Latin American countries.
Market Dynamics
The healthcare industry is experiencing a growing demand for qualified professionals, driving the need for innovative and accessible educational solutions. Afya is well-positioned to capitalize on this trend through its comprehensive offerings in both traditional and online education. The increasing adoption of technology in healthcare education also presents significant opportunities for growth.
Competitors
- Key Competitors: Kroton Educacional (KROT3.SA), Ser Educacional (SEER3.SA), Yduqs (YDUQ3.SA)
- Market Share Comparison: Afya holds the largest market share among private universities in Brazil for medical degrees. However, competitors like Kroton and Ser Educacional have a broader presence across other educational programs.
- Competitive Advantages: Afya's strong focus on healthcare, digital platform, and brand recognition in Brazil are its key competitive advantages.
Potential Challenges and Opportunities
Key Challenges
- Competition: Afya faces stiff competition from established players in the education sector.
- Regulatory Landscape: Changes in regulations affecting the healthcare education sector could impact the company's operations.
- Debt Management: Managing the company's debt level will be crucial for its long-term financial health.
Opportunities
- International Expansion: Expanding into new markets, particularly in Latin America, presents significant growth potential.
- Partnerships: Strategic partnerships with healthcare institutions and technology providers can offer new avenues for collaboration and innovation.
- Innovation: Continuous innovation in educational delivery and technology adoption can help Afya maintain its competitive edge.
Recent Acquisitions
In the past 3 years, Afya has made several acquisitions, including:
- UniA (2021): Acquisition of a leading private university in the state of Bahia, Brazil, strengthening Afya's presence in the Northeast region.
- Medcel (2018): Acquisition of a leading digital platform for medical education in Brazil, solidifying Afya's position in the online education market.
- FAM (2019): Acquisition of a medical school in Manaus, Amazon, expanding Afya's reach to a new region and increasing its student base.
These acquisitions align with Afya's strategy of expanding its educational offerings and geographical reach, particularly in the digital education space.
AI-Based Fundamental Rating
Based on an AI-powered rating system, Afya Ltd receives a rating of 8/10. This rating is supported by its strong financial performance, leading market position in the Brazilian medical education market, and growth potential in both traditional and online education segments. However, factors such as high competition and debt levels are also considered in the rating.
Sources and Disclaimers
- Financial information sourced from Afya Ltd.'s annual reports and investor presentations.
- Market share data sourced from industry reports and company presentations.
- This overview is intended for informational purposes only and should not be considered investment advice. Please conduct your own research and due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Afya Ltd
Exchange | NASDAQ | Headquaters | Nova Lima, MG, Brazil |
IPO Launch date | 2019-07-19 | CEO | - |
Sector | Consumer Defensive | Website | https://www.afya.com.br |
Industry | Education & Training Services | Full time employees | - |
Headquaters | Nova Lima, MG, Brazil | ||
CEO | - | ||
Website | https://www.afya.com.br | ||
Website | https://www.afya.com.br | ||
Full time employees | - |
Afya Limited operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. Further, it offers iClinic, a practice management software; educational health and medical imaging solutions through an interactive platform; Cliquefarma, a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices; Shosp, a clinical management software; RX PRO, a solution that connects physicians with the pharmaceutical industry; and Glic, a free diabetes care and management app solution for physicians and patients. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.